Mingbo Cao
No. 600, Tianhe Road
Guangzhou, 510530, China
Guangzhou, 510530, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Exosome-derived hsa_circ_0007132 promotes lenvatinib resistance by inhibiting the ubiquitin-mediated degradation of NONO.
Journal: Non-coding RNA research
Published: February 17, 2025
Machine learning-assisted multi-dimensional transcriptomic analysis of cytoskeleton-related molecules and their relationship with prognosis in hepatocellular carcinoma.
Journal: Scientific reports
Published: February 11, 2025
Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: January 22, 2025
Comparative analysis of hepatectomy for HCC with PVTT: Insights from a 30-year single-center experience: Hepatectomy for HCC with PVTT.
Journal: Surgical oncology
Published: December 20, 2024
Post-treatment adverse events ranking in targeted immunotherapy for hepatocellular carcinoma: A network meta-analysis based on risk probability assessment.
Journal: Critical reviews in oncology/hematology
Published: December 08, 2024
CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 01, 2024
CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axis.
Journal: Genomics
Published: April 22, 2024
A new strategy for overcoming drug resistance in liver cancer: Epigenetic regulation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 09, 2024
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: November 17, 2023
Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: May 06, 2023
Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis.
Journal: International journal of biological sciences
Published: April 14, 2023
Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis.
Journal: Annals of translational medicine
Published: May 07, 2022
Last Updated: 09/26/2026